These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20595094)
1. TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study. Mallo M; Osca G; Solórzano J; Arenillas L; Florensa L; Solé F Haematologica; 2010 Oct; 95(10):1798-800. PubMed ID: 20595094 [No Abstract] [Full Text] [Related]
2. Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 cases. Klaus M; Psaraki A; Mastrodemou S; Pyrovolaki K; Mavroudi I; Kalpadakis C; Papadaki HA Leuk Res; 2011 Mar; 35(3):413-5. PubMed ID: 21087791 [TBL] [Abstract][Full Text] [Related]
3. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia. Kosmider O; Gelsi-Boyer V; Ciudad M; Racoeur C; Jooste V; Vey N; Quesnel B; Fenaux P; Bastie JN; Beyne-Rauzy O; Stamatoulas A; Dreyfus F; Ifrah N; de Botton S; Vainchenker W; Bernard OA; Birnbaum D; Fontenay M; Solary E; Haematologica; 2009 Dec; 94(12):1676-81. PubMed ID: 19797729 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia. Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757 [No Abstract] [Full Text] [Related]
5. Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Grossmann V; Kohlmann A; Eder C; Haferlach C; Kern W; Cross NC; Haferlach T; Schnittger S Leukemia; 2011 May; 25(5):877-9. PubMed ID: 21339759 [No Abstract] [Full Text] [Related]
6. Targeted re-sequencing of TET2 in Taiwanese patients with myelodysplastic/myeloproliferative neoplasms. Lin HC; Hwang DY; Lim KH Med Oncol; 2016 Aug; 33(8):92. PubMed ID: 27418193 [No Abstract] [Full Text] [Related]
7. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343 [TBL] [Abstract][Full Text] [Related]
8. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Yamazaki J; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Shen L; Kantarjian HM; Estecio MR; Jelinek J; Godley LA; Issa JP Epigenetics; 2012 Feb; 7(2):201-7. PubMed ID: 22395470 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia. Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812 [TBL] [Abstract][Full Text] [Related]
13. AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis. Liu S; Li C; Bo L; Dai Y; Xiao Z; Wang J Cancer Genet Cytogenet; 2004 Jul; 152(2):172-4. PubMed ID: 15262442 [No Abstract] [Full Text] [Related]
14. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. Kohlmann A; Grossmann V; Klein HU; Schindela S; Weiss T; Kazak B; Dicker F; Schnittger S; Dugas M; Kern W; Haferlach C; Haferlach T J Clin Oncol; 2010 Aug; 28(24):3858-65. PubMed ID: 20644105 [TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Smith AE; Mohamedali AM; Kulasekararaj A; Lim Z; Gäken J; Lea NC; Przychodzen B; Mian SA; Nasser EE; Shooter C; Westwood NB; Strupp C; Gattermann N; Maciejewski JP; Germing U; Mufti GJ Blood; 2010 Nov; 116(19):3923-32. PubMed ID: 20693430 [TBL] [Abstract][Full Text] [Related]